In Sweden, healthcare is primarily public and funded through state taxes, which are distributed to county councils, who then allocate resources to their counties’ primary care centers and hospitals. Historically, this allocation of funds has been based on DRG’s at the hospital level, and on age and gender adjustments at the primary care level. After Sweden passed the freedom of choice model, which allows patients to choose their primary care provider, a better risk adjusted resource allocation system was required.
In addition, ACG(R) International solidified its presence in Sweden by partnering with a healthcare government agency. With access to its national drug register database, the ACG International team was able to test the pharmacy based predictive model’s (Rx-PM™) validity as a risk adjustment tool in the Swedish context. The year-long study, conducted on a database capturing the entire Swedish population, showed that the Rx-PM model not only works very well for Swedish pharmaceutical data, but it also adds the potential of applying pharmaceutical data to additional applications of the system such as provider profiling.